Fleury, Isabelle, and Eva Laverdure. 2023. “Bispecific Antibodies and Chimeric Antigen Receptor (CAR) T-Cell Therapy for Indolent Lymphoma”. Canadian Hematology Today 2 (3). Toronto, Canada:5-11. https://doi.org/10.58931/cht.2023.2338.